Predicting BCG Response

Abroad (travel likely)Recruiting

Conditions

Bladder Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Cedars-Sinai Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Amy Oppenheim) · Amy.Oppenheim@cshs.org · 310-423-3713
    Contact: Principal Investigator (Hideki Furuya, PhD)
  • UCLA, Los Angeles, California, United States

    Contact: Study coordinator (Arnold Chin, MD)
  • UCSF, San Francisco, California, United States

    Contact: Study coordinator (Sima Porten, MD)
  • University of Texas Southwestern, Dallas, Texas, United States

    Contact: Study coordinator (Perla Lopez) · perla.lopez@utsouthwestern.edu · 214-648-9195
  • University of Queensland, Brisbane, Australia

    Contact: Study coordinator (Wanyi Jiang) · wanyi.jiang@health.qld.gov.au
    Contact: Principal Investigator (Handoo Rhee, MD)
    Fernando Guimaraes, PhD (Sub-investigator)
  • Kyoto University, Kyoto, Japan

    Contact: Study coordinator (Yuki Kita, MD)
Study leads
  • Charles Rosser, MD

    Study Director

    Nonagen Bioscience Corporation

  • Hideki Furuya, PhD

    Principal Investigator

    Cedars-Sinai Medical Center